Scale-up and synthesis of a TAU oligomer inhibitor to initiate IND enabling studies for ad and adrd
Ended Project Grant Awarded Last action
- Award ID
- R44AG062021
- Recipient
-
Oligomerix Inc. UEI MHB5HVJVAK87
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,499,352
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- Bronx, NY 10461, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $999,937 | |
| Amendment | $999,982 | |
| Original award | $499,433 |
Quick answers
Who received award R44AG062021?
R44AG062021 was awarded to Oligomerix Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2018.
How much is award R44AG062021 worth?
$2,499,352 has been obligated on R44AG062021.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award